Arkolith/Insider Trading/VIVO/Form 4

Kenny John P.

Chief Executive Officer, DirectorMERIDIAN BIOSCIENCE INC (VIVO) · full profile →Form 4 · filed Jun 24, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.9M
Net Open-Market Flow
-$1.9M
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2022Option exercise(M)5K$14.50$78K270K
Jun 23, 2022Sell(S)20K$29.98$598K265K
Jun 23, 2022Option exercise(M)15K$10.10$148K285K
Jun 22, 2022Option exercise(M)45K$14.50$647K310K
Jun 22, 2022Sell(S)45K$29.72$1.3M265K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 23, 2022Option exercise(M)5K—$00
Jun 23, 2022Option exercise(M)15K—$0141K
Jun 22, 2022Option exercise(M)45K—$05K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-22-018097) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML